Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hartman

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Vaccine|August 1, 1996
Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infectionL L Van De Verg, N O Bendiuk, K Kotloff, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 25, 2011
Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imagingCristina L Zavaleta, Keith B Hartman, Zheng Miao, et al.
Journal of Medicinal Chemistry|March 31, 1995
3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873)J T Strupczewski, K J Bordeau, Y Chiang, et al.
Microbiology (Reading, England)|April 30, 2014
Identification of potential drug targets in Salmonella enterica sv. Typhimurium using metabolic modelling and experimental validationHassan B Hartman, David A Fell, Sergio Rossell, et al.
Infection and Immunity|January 27, 2004
Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteersDavid E Katz, Trinka S Coster, Marcia K Wolf, et al.
Journal of Clinical Microbiology|September 13, 2013
Novel fastidious, partially acid-fast, anaerobic Gram-positive bacillus associated with abscess formation and recovered from multiple medical centersS M Harrington, M Bell, K Bernard, et al.
Contrast Media & Molecular Imaging|January 27, 2010
Serine-derivatized gadonanotubes as magnetic nanoprobes for intracellular labelingAmy A Hassan, Bonita Tak-Yee Chan, Lesa A Tran, et al.
Infection and Immunity|December 1, 1996
Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization modelsL L Van De Verg, A B Hartman, A K Bhattacharjee, et al.
Journal of Medicinal Chemistry|July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophreniaN J Hrib, J G Jurcak, D E Bregna, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formationPaolo Bellotti, Zachary Ladd, Victoria Leroy, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Vaccine|August 1, 1996
Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infectionL L Van De Verg, N O Bendiuk, K Kotloff, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 25, 2011
Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imagingCristina L Zavaleta, Keith B Hartman, Zheng Miao, et al.
Journal of Medicinal Chemistry|March 31, 1995
3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873)J T Strupczewski, K J Bordeau, Y Chiang, et al.
Microbiology (Reading, England)|April 30, 2014
Identification of potential drug targets in Salmonella enterica sv. Typhimurium using metabolic modelling and experimental validationHassan B Hartman, David A Fell, Sergio Rossell, et al.
Infection and Immunity|January 27, 2004
Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteersDavid E Katz, Trinka S Coster, Marcia K Wolf, et al.
Journal of Clinical Microbiology|September 13, 2013
Novel fastidious, partially acid-fast, anaerobic Gram-positive bacillus associated with abscess formation and recovered from multiple medical centersS M Harrington, M Bell, K Bernard, et al.
Contrast Media & Molecular Imaging|January 27, 2010
Serine-derivatized gadonanotubes as magnetic nanoprobes for intracellular labelingAmy A Hassan, Bonita Tak-Yee Chan, Lesa A Tran, et al.
Infection and Immunity|December 1, 1996
Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization modelsL L Van De Verg, A B Hartman, A K Bhattacharjee, et al.
Journal of Medicinal Chemistry|July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophreniaN J Hrib, J G Jurcak, D E Bregna, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formationPaolo Bellotti, Zachary Ladd, Victoria Leroy, et al.
Pageof 14